Cytokines in WBC-reduced apheresis pcs during storage: A comparison of two WBC-reduction methods

Transfusion

Volumn 40, Issue 9, 2000, Pages 1118-1126

  Wadhwa, Meenu ^a,b   Jerhard Seghatchian, M ^a,b   Dilger, Paula ^a,b   Sands, Dawn ^a,b   Krailadisiri, Pranee ^a,b   Contreras, Marcela ^a,b   Thorpe, Robin ^a,b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THROMBOCYTE CONCENTRATE; THROMBOCYTE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APHERESIS; ARTICLE; BLOOD FILTRATION; COMPARATIVE STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEUKOCYTE; MEASUREMENT; THROMBOCYTE PRESERVATION;

BETA-THROMBOGLOBULIN; BLOOD PLATELETS; BLOOD PRESERVATION; CHEMOKINE CCL2; CYTOKINES; FILTRATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKAPHERESIS; PLATELET FACTOR 4; RANTES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033818711     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40091118.x     Document Type: Article

References (43)

1. The association of febrile transfusion reactions with leucoagglutinins
2. Nonhemolytic febrile transfusion reactions: Quantitative effects of blood components with emphasis on isoantigenic incompatibility of WBCs
3. Reactions to platelet transfusion: The effect of the storage time of the concentrate
4. Increased tumor necrosis factor α (TNFα, interleukin-1 (IL-1), and interleukin-6 (IL-6) levels in the plasma of stored PCs: Relationship between TNFα and IL-6 levels and febrile transfusion reactions
5. Febrile reactions to platelet transfusion: The effect of increased interleukin-6 levels in concentrates prepared by the platelet-rich plasma method
6. Chemokines in stored PCs
7. Cytokine levels in PCs: Quantitation by bioassays and immunoassays
8. The relationship between the duration of platelet storage and the development of transfusion reactions
9. The role of the plasma from PCs in transfusion reactions
10. Effect of prestorage WBC removal on the cytokine levels in stored PCs
11. Effect of filtration of PCs on the accumulation of cytokines and platelet release factors during storage
12. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage
13. Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components
14. Negatively charged WBC filters significantly enhances kallikrein and thrombin like activity of PCs
15. More on kininogen measurements in PCs that are white cell (WBC) reduced with WBC-reduction filters
16. Current methods for the preparation of PCs
17. Quantitative biological assays for individual cytokines
18. Cytokine generation in stored PCs
19. Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter
20. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets
21. Improved removal of white cells with minimal platelet loss by filtration of apheresis platelets during collection
22. White cell subsets in apheresis and filtered PCs
23. Interleukin-8 and other CXC chemokines
24. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
25. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils
26. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes
27. RANTES is a chemotactic and activating factor for human eosinophils
28. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors
29. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils
30. CC chemokines in allergic inflammation
31. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils
32. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes
33. Red blood cells are a sink for interleukin-8, a WBC chemotaxin
34. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor
35. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells
36. Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of PCs
37. Transforming growth factor β: A matter of life and death
38. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure
39. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes
40. Deactivation of macrophages by transforming growth factor-β
41. Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells
42. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies
43. Mumps virus infection increases sensitivity to tumour necrosis factor-alpha and gamma-interferon induced cytotoxicity in a human insulinoma cell line